asco 2019: leslie popplewell, m.d.
Published 5 years ago • 143 plays • Length 1:22
Download video MP4
Download video MP3
Similar videos
-
1:05
leslie popplewell, m.d., at ash 2019
-
1:22
meet hematologist leslie popplewell, m.d. | city of hope
-
1:25
leslie popplewell, m.d., on mantle cell lymphoma | #asco21
-
1:43
leslie popplewell, m.d., on new mantle cell lymphoma research | #asco21
-
2:10
adaptive immunotherapy research | city of hope
-
3:24
leslie popplewell, md, provides thoughts on the unique moa on the newly fda approved tazemetostat
-
3:26
updates to the esmo guidelines for the treatment of mantle cell lymphoma
-
0:59
lili brillstein, m.p.h., shares her thoughts on the keys to success to make episodes of care work
-
0:35
leslie popplewell, md , considers the use of car-t cell therapies in aggressive b-cell lymphomas
-
0:54
leslie popplewell, md , on the role of car-t cell therapy in aggressive b-cell lymphomas
-
0:43
leslie popplewell, md, summarizes the role of checkpoint inhibitors in the treatment of lymphomas
-
59:11
blood and immune system related cancers with dr. leslie popplewell
-
1:07
leslie popplewell, md, considers whether there is sufficient evidence supporting bridging therapy
-
1:06
leslie popplewell, md, offers opinion on the next frontier in the development of car-t treatment
-
1:26
leslie popplewell, md, facp, on the challenges of delivering car t-cell therapy to lymphoma patients
-
1:38
leslie popplewell, md, facp, describes how engineered toxin bodies work as an anti-cancer treatment
-
1:32
leslie popplewell, md, provides perspective on the elara study regarding follicular lympohoma
-
2:07
leslie popplewell, md, provides thoughts on the role yescarta will play in low grade nhl management
-
2:00
leslie popplewell, md, facp, on the management of adverse events associated with car t-cell therapy
Clip.africa.com - Privacy-policy